Announcements and Notices - [Discloseable Transaction] DISCLOSEABLE TRANSACTION IN RELATION TO CONSTRUCTION AGREEMENT FOR THE GLOBAL RESEARCH AND DEVELOPMENT CENTRE
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Announcements and Notices - [Issue of Shares under a General Mandate / Other - Miscellaneous] (1) GRANT OF AWARD SHARES UNDER RESTRICTED SHARE AWARD SCHEME (2) ISSUE OF NEW SHARES UNDER GENERAL MANDATE (3) AMENDMENT TO SCHEME RULES
Announcements and Notices - [Terms of Reference of Other Board Committees] Terms of Reference for the Strategy and ESG Committee
Announcements and Notices - [Continuing Connected Transaction] CONTINUING CONNECTED TRANSACTIONS IN RELATION TO TECHNICAL SERVICE AGREEMENT AND BUSINESS DEVELOPMENT SERVICE AGREEMENT
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - ENTERING INTO OF AN EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH A WHOLLY-OWNED SUBSIDIARY OF JIMIN KEXIN PHARMACEUTICAL IN RESPECT OF PUSINTIN (BEVACIZUMAB INJECTION, PUSINTIN) FOR THE MAINLAND CHINA MARKET
Announcements and Notices - [Connected Transaction] CONNECTED TRANSACTION IN RELATION TO DISPOSAL OF LISTED SECURITIES
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Announcements and Notices - [Inside Information / Other - Business Update] INSIDE INFORMATION ANNOUNCEMENT - MARKETING APPROVAL FOR PUSINTIN (TAB008, BEVACIZUMAB INJECTION, PUSINTIN) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Discloseable Transaction] DISCLOSEABLE TRANSACTION IN RELATION TO FORMATION OF JOINT VENTURE
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Financial Statements/ESG Information - [Interim/Half-Year Report] INTERIM REPORT 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report] 2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) REPORT
Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 JUNE 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL FOR TEMOZOLOMIDE CAPSULE (TOZ309) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - MARKETING APPROVAL FOR MEGESTROL ACETATE ORAL SUSPENSION (TOM218) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Financial Statements/ESG Information - [Annual Report] ANNUAL REPORT 2020
Next Day Disclosure Returns - [Others] Next Day Disclosure Return
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Announcements and Notices - [Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL APPLICATION OF TAB014 AUTHORIZED BY FDA
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020